Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)

Clinical trial NCT03992417 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03992417
Sponsor: Sanofi
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Dermatitis Atopic

Start date: 2019-06-11
Primary completion: 2027-03-31
Enrollment: 955

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.